期刊文献+

失代偿期肝硬化患者大肠埃希菌血流感染临床及预后分析 被引量:13

Clinical and prognostic analysis of decompensated cirrhosis patients Escherichia coil bloodstream infections
原文传递
导出
摘要 目的分析失代偿期肝硬化患者大肠埃希菌血流感染的临床特点及耐药性,探讨影响疾病预后的危险因素。方法回顾性分析2009-2012年在解放军第三。二医院住院的失代偿期肝硬化患者血流感染大肠埃希菌患者的临床资料,以是否存活作为预后判定的终点指标,分别进行单因素及多因素Logistic回归分析,探讨影响患者预后的危险因素。结果2009-2012年失代偿期肝硬化患者血流感染大肠埃希菌共211例,超广谱B内酰胺酶(ESBLs)阳性80株,阳性率37.9%。多数血流感染来源不明或不确定,ESBLs阳性大肠埃希菌耐药性高于ESBLs阴性大肠埃希菌,但两者在年龄、性别、基础疾病、原发病灶、体温峰值、白细胞计数及中性粒细胞百分率等方面比较差异均无统计学意义。本组患者治疗后治愈好转154例,无效及死亡共57例,无效病死率达27.0%,通过对生存组和死亡组的单因素及多因素Logistic回归分析提示,年龄大、脉搏不正常、肝衰竭、肝性脑病、感染性休克、急性肾损伤、消化道出血是预后差的危险因素,体温超过39℃(OR=0.301)对降低病死率具有保护作用。通过建立的Logistic预测概率模型,得到ROC曲线,曲线下面积为0.898。结论失代偿期肝硬化患者血流感染大肠埃希菌病情危重,预后不良,早期进行有效的抗感染治疗和积极预防严重并发症的发生可以降低病死率。 Objective To investigate the clinical characteristic and drug resistance of decompensated cirrhosis patients bloodstream infections causing by Escherichia coli, and determine risk factors for mortality among patients with bloodstream infections. Methods The clinical data and drug susceptibility of decompensated cirrhosis patients Escherichia coli bloodstream infections from 2009 to 2012 in 302 hospital of PLA were retrospectively analyzed. Univariable and multivariable Logistic regression was used to identify independent risk factors for all-cause mortality. Results A total 211 strains of E. coli were isolated from decompensated cirrhosis inpatients, 80 strains ESBLs detecting were positive, positive rate was 37.9%. Most of infection source were uncertain. The drug resistance of ESBLs positive strains was higher than ESBLs negative strains, but no statistical difference existed in age, sex, basic disease, infection source, peak temperature, white blood cell count, the percentage of neutrophils between ESBLs positive strains and negative strains. 154 patients were survived and 57 patients were died after treatment, with a mortality of 27.01%. On multivariate analysis, independent risk factors for in-hospital mortality were old age [odds ratio (OR) = 2.429], abnormal pulse ( OR = 2.977), liver failure ( OR = 11. 159), hepatic encephalopathy( OR = 2. 524 ), septic shock ( OR = 8. 837 ), acute kidney injury ( OR = 3. 758 ), gastrointestinal bleeding( OR =4. 118). Body temperature of 〉 39 ℃ (OR =0. 301 ) had protective effect to lower mortality. A Logistic probobility model was created by adding points for each independent risk factor, and had a c-statistic of 0. 898. Conclusions Due to decompensated cirrhosis patients Escherichia coli bloodstream infection severity and bad prognosis, early effective antimicrobial therapy and severe complication prevention should be taken to reduce mortality.
出处 《中华医学杂志》 CAS CSCD 北大核心 2015年第13期1006-1011,共6页 National Medical Journal of China
基金 全军医学科技“十二五”科研项目重点课题(BWS11C-073)
关键词 肝硬化 肠出血性大肠杆菌 失代偿期 预后 Liver cirrhosis Enterohemorrhagic escherichia coli Decompensated Prognosis
  • 相关文献

参考文献16

二级参考文献67

  • 1俞云松.超广谱β-内酰胺酶研究进展[J].中华医学杂志,2006,86(9):641-644. 被引量:95
  • 2骆俊,吴菊芳,朱德妹,李光辉,张婴元,汪复.上海市华山医院血流感染患者的病原学和临床研究[J].中华传染病杂志,2006,24(1):29-34. 被引量:40
  • 3郭桐生,曲芬,毛远丽,崔恩博,鲍春梅,张菊玲.慢性肝病患者血培养分离菌分布特征及耐药谱研究[J].内科急危重症杂志,2006,12(3):105-107. 被引量:4
  • 4褚云卓,年华,邓宇欣,欧阳金鸣,王倩.血培养的菌谱调查及耐药性分析[J].中华医院感染学杂志,2007,17(4):472-474. 被引量:50
  • 5Johnson DH , Cunha BA. Infections in cirrhosis. Infect Dis Clin North Am , 2001 ,15:363-371.
  • 6Borzio M , Salerno F , Piantoni L , et al . Bacterial infection in patients with advanced cirrhosis: a multi-center prospective study. Dig Liver Dis, 2001 ,33:41-48.
  • 7Kim YK, Pal H, Lee HJ, et al. Bloodstream infections by extended spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneurnoniae in children: epidemiology and clinical outcome. Antimicrob Agents Chemother, 2002, 46 : 1481-1491.
  • 8Du B, Long Y, Liu HZ, et al. Extended spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical Outcome. Intensive Care Med, 2002,28: 1718 1723.
  • 9Mendelson G, Hait V, Ben-Israel J, et al. Prevalence and risk factors of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in an Israeli long-term care facility. Eur J Clin Microbiol Infect Dis, 2005,24:17-22.
  • 10Calbo E, Romani V, Xercavlns M, et al. Risk factors fur community onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J Antimicrob Chemother, 2006,57 : 780-783.

共引文献149

同被引文献98

  • 1Mohd Talha Noor,Piyush Manoria.Immune Dysfunction in Cirrhosis[J].Journal of Clinical and Translational Hepatology,2017,5(1):50-58. 被引量:18
  • 2Michela Emma Burlone,Stefano Fangazio,Alessandro Croce,Elisa Ceriani,Rachele Rapetti,Cristina Rigamonti,Carlo Smirne,Stelvio Tonello,Paolo Ravanini,Rosalba Minisini,Mario Pirisi.Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment[J].Hepatoma Research,2020,6(2):1-10. 被引量:1
  • 3丁娟娟,吕晓菊,宗志勇,熊亚莉.阴沟肠杆菌血流感染52例临床分析[J].中国感染与化疗杂志,2007,7(2):116-118. 被引量:9
  • 4Hamacher L, Dorfelt R, Muller M, et al. Serum cardiac troponin Iconcentrations in dogs with systemic inflammatory response syn-drome[J].J Vet Intern Med, 2015,29(1):164-170.
  • 5Bemardi M, Moreau R, Angeli P, et al. Mechanisms of decompen-sation and organ failure in cirrhosis: From peripheral arterial va-sodilation to systemic inflammation hypothesis [J]. J Hepatol, 2015,63(5):1272-1284.
  • 6Lin S, Huang Z,Wang M, et al. Interleukin-6 as an early diagnosticmarker for bacterial sepsis in patients with liver cirrhosis [J]. J CritCare, 2015,30(4):732-738.
  • 7Reuken PA, Kussmann A, Kiehntopf M, et al. Imbalance of vonWillebrand factor and its cleaving protease ADAMTS13 during sys-temic inflammation superimposed on advanced cirrhosis [J]. LiverInt, 2015,35(1):37-45.
  • 8American College of Chest Physicians/Society of Critical CareMedicine Consensus Conference: definitions for sepsis and organfailure and guidelines for the use of innovative therapies in sepsis[J]. Crit Care Med, 1992,20(6):864-874.
  • 9Arvaniti V,D'Amico G, Fede G, et al. Infections in patients withcirrhosis increase mortality four-fold and should be used in deter-mining prognosis [J]. Gastroenterology, 2010,139 (4):1246-1256,1251-1256.
  • 10Mehta G,Mookerjee R P, Sharma V,et al. Systemic inflammationis associated with increased intrahepatic resistance and mortality inalcohol-related acute-on-chronic liver failure [J]. Liver Int, 2015,35(3):724-734.

引证文献13

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部